Emergence of NNRTI drug resistance mutations after single-dose nevirapine exposure in HIV type 1 subtype C-infected infants in India

AIDS Research and Human Retroviruses

Volumn 23, Issue 5, 2007, Pages 682-685

  Kurle, Swarali N ^a   Gangakhedkar, Raman R ^a   Sen, Sourav ^b   Hayatnagarkar, Shilpa S ^a   Tripathy, Srikanth P ^a   Paranjape, Ramesh S ^a,c  

^a NATIONAL AIDS RESEARCH INSTITUTE   (India)

^b Department of Pathology Command Hospital Southern Command   (India)

^c Maharashtra Industrial Development Corporation India   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CELL DNA; DELAVIRDINE; EFAVIRENZ; GAG PROTEIN; NEVIRAPINE; POL PROTEIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR; VIRUS ENVELOPE PROTEIN; ZIDOVUDINE;

ADULT; ARTICLE; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INFANT; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE DRUG DOSE; VERTICAL TRANSMISSION; VIRUS MUTATION; VIRUS TRANSMISSION;

BENZOXAZINES; DELAVIRDINE; DISEASE TRANSMISSION, VERTICAL; DRUG RESISTANCE, VIRAL; FEASIBILITY STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; INDIA; INFANT; INFANT, NEWBORN; MOLECULAR SEQUENCE DATA; MUTATION; NEVIRAPINE; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 34249882818     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.0167     Document Type: Article

References (23)

1. Working Group on Mother-to-Child Transmission of HIV. J Acquir Immune Defic Syndr Hum Retroviral 1995:8:506.
2. Report of a consensus workshop: Maternal factors involved in mother to child transmission of HIV-1. AIDS 1992;5:1019-1029.
3. Datta P, Embree JE, Kreiss JK, et al.: Mother to child transmission of type-1. Report from the Nairobi study. J Infect Dis 1994;170:1134-1140.
4. Kumar RM, Uduman SA, Khurranna AK. A prospective study of mother-to-infant HIV transmission in tribal women from India. J Acquir Immune Defic Syndr 1995;9:238-242.
5. Dongaokar D. Prevention of mother-to-child transmission of HIV-1 using antiretroviral drug-zidovudine. J Obstet Gyn Ind 2003;53:563-567.
6. Guay LA, Musoke P, Fleming T, et al.: Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795-802.
7. Eshleman SH and Jackson JB: Nevirapine resistance after single dose prophylaxis. AIDS Rev 2002;4:59-63.
8. Jackson JB, Becker-Pergola G, Guay LA, et al.: Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission. AIDS 2000;14:F111-115.
9. Cunningham CK, Chaix ML, Rekacewicz C, et al.: Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: A substudy of pediatric AIDS clinical trials group protocol 316. J Infect Dis 2002;186:181-188.
10. Kantor R, Lee E, Johnston E, et al.: Rapid flux in non-nucleoside reverse transcriptase inhibitor resistance mutations among subtype C HIV-1-infected women after single dose nevirapine. Antiviral Ther 2003;8:S85.
11. Conway B, Wainberg MA, Hall D, et al.: Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine. AIDS 2001;15:1269-1274.
12. Havlir DV, Eastman S, Gamst A, and Richman DD: Nevirapine-resistant human immunodeficiency virus: Kinetics of replication and estimated prevalence in untreated patients. J Virol 1996;70:7894-7899.
13. Eshleman S, Hoover D, Chen S, et al.: Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP. J Infect Dis 2005;192:30-36.
14. Choo Beng Chew, Simon J. Potter, Bin Wang, et al.: Assessment of drug resistancemutations in plasma and peripheral blood mononuclear cells at different plasma viral loads in patients receiving HAART. J Clin Virol 2005;33:206-216.
15. Loredana Sarmati, Emanuele Nicastri, Ilaria Uccella, et al.: Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing. J Clin Microbiol 2003;Apr:1760-1762.
16. Devereux HL, Loveday C, Youle M, et al.: Substantial correlation between HIV type 1 drug-associated resistance mutations in plasma and peripheral blood mononuclear cells in treatment-experienced patients. AIDS Res Hum Retroviruses 2000;16:1025-1030.
17. Soto-Ramirez LE, Tripathy S, Renjifo B, and Essex M: HIV-1 pol sequences from India fit distinct subtype pattern. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13(4):299-307.
18. Lai Renu B,'Chakrabarti Sekhar, and Yang Chunfu: Impact of genetic diversity of HIV-1 on diagnosis, antiretroviral therapy & vaccine development, India. Indian J Med Res 2005;121:287-314.
19. Flys T, Nissley DV, Claasen CW, et al.: Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012. J Infect Dis 2005;192(1):1-3.
20. Gatanaga H, Hachiya A, Kimura S, and Oka S: Mutations other than 103N in human immunodeficiency virus type 1 reverse transcriptase (RT) emerge from K103R polymorphism under non-nucleoside RT inhibitor pressure. Virology 2006;344(2):354-362.
21. Deshpande A, Recordon-Pinson P, Deshmukh R, et al.: Molecular characterization of HIV type 1 isolates from untreated patients of Mumbai (Bombay), India, and detection of rare resistance mutations. AIDS Res Hum Retroviruses 2004;20(9):1032-1035.
22. Balakrishnan P, Kumarasamy N, Kantor R, et al.: HIV type 1 genotypic variation in an antiretroviral treatment-naive population in southern India. AIDS Res Hum Retroviruses 2005;21(4):301-305.
23. Simmonds P, Zhang LQ, McOmish F, et al.: Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated proviral populations in vivo: Implications for models of HIV pathogenesis. J Virol 1991;65(11):6266-6276.